Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ADMS

Adamas Pharmaceuticals (ADMS)

Adamas Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADMS
DateTimeSourceHeadlineSymbolCompany
02/15/20225:35AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
01/26/202210:01AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
12/10/20217:53AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
12/02/20215:15AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/24/20213:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/24/20213:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/24/20213:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/24/20213:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/24/20213:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/24/202110:54AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/24/202110:47AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/24/202110:46AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/24/202110:43AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/24/20218:28AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/24/20218:18AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/24/20218:17AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/24/20218:12AMGlobeNewswire Inc.Supernus Pharmaceuticals Completes Acquisition of Adamas PharmaceuticalsNASDAQ:ADMSAdamas Pharmaceuticals Inc
11/23/20217:22AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/23/20217:00AMGlobeNewswire Inc.Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender OfferNASDAQ:ADMSAdamas Pharmaceuticals Inc
11/23/20215:05AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/18/20217:58AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/10/20213:03PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/01/20213:55PMEdgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ADMSAdamas Pharmaceuticals Inc
10/25/20214:24PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
10/25/202110:26AMEdgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:ADMSAdamas Pharmaceuticals Inc
10/25/20219:22AMEdgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:ADMSAdamas Pharmaceuticals Inc
10/19/20213:27PMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ADMSAdamas Pharmaceuticals Inc
10/13/20214:14PMEdgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ADMSAdamas Pharmaceuticals Inc
10/12/20216:56AMEdgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:ADMSAdamas Pharmaceuticals Inc
10/12/20216:05AMEdgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:ADMSAdamas Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ADMS